The U.S. Food and Drug Administration (FDA) has recently issued a warning about the drug Abilify. Abilify, which is also known as Abilify Maintena, Astrida, and manufactured in generic form, is typically used as an anti-psychotic medication. According to the FDA, there have been reports of adverse events (side effects) linking the drug to various compulsive or uncontrollable urges to engage in certain high risk behavior including gambling, binge eating, shopping, and sex.
These instances of impulsive behavior have been linked to taking the drug, and have been seen to stop once the drug is stopped. But there is no telling how much damage could be done during the time a patient is suffering from these uncontrollable urges as described by the FDA. Continue reading